Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by MisterBon Dec 18, 2009 10:44am
466 Views
Post# 16600691

RE: RE: Why

RE: RE: WhyFolks,

I had an order in for 3k at $2.40 today and 2k got filled.  Upon seeing the YA news, I cancelled my order, but am holding 2k shares. I have a bunch of experience with YA and all I can say is they are poison.

Look up YA or Yorkville advisors, who previously went by the name Cornell Capital.  They are involved in a bunch of PIPE investments and Convertible Debentures - and the Shareprice generally falls when they are involved. There are lawsuits against them, etc.

I would suggest you do some DD on this company as they are generally regarded as poison and a huge detriment to SP appreciation.  I am not pleased to learn of their involvment with RVX (on the day I finally buy, no less).  I've been through this with other companies that use them and I can only hope that management uses them VERY wisely, if at all.  They've also been known to short.

Look at MOBL.OB and NEOM.OB as examples from a couple years ago.  I could go on and on, but I believe it is better you do your own DD rather than getting it from me (and questioning my motives)...

B
Bullboard Posts